Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-14

Clinical Trial Update: Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluated fingolimod for treating cerebral edema after intracerebral hemorrhage. The study has completed and results were posted (2025-01-14…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Intracerebral Hemorrhage, Cerebral Edema | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-01-14